Timo Minssen (Former)
71 – 80 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Assessing the Inventiveness of Bio-Pharmaceuticals under European and US Patent Law - A comparative study with special emphasis on DNA- and protein-related inventions
(2012)
- Thesis › Doctoral thesis (monograph)
-
Mark
The US Supreme Court in Mayo v Prometheus - taking the fire from or to biotechnology and personalized medicine?
- Contribution to journal › Article
-
Mark
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO--Part II1
- Contribution to journal › Article
-
Mark
What intent, whose intent and to what extent?: The Knowledge requirement in indirect patent infringement
- Contribution to journal › Article
-
Mark
The industrial application requirement for biotech inventions in light of recent EPO & UK case law:: A plausible "hunting license"?"
- Contribution to journal › Article
- 2011
-
Mark
US Patent Eligibility in the Wake of Bilski v Kappos: "Business as Usual" in an Age of New Technologies?
- Contribution to journal › Article
-
Mark
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO--Part I
- Contribution to journal › Article
-
Mark
Contribution to case law summaries and comments: Tri-lingual
(2011)
- Book/Report › Book
-
Mark
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO – Part I
- Contribution to journal › Article
- 2010
-
Mark
Meanwhile on the Other Side of the Pond: Why Biopharmaceutical Inventions that Were “Obvious to Try” Still Might Be Non-Obvious – Part I
- Contribution to journal › Article